T1DGC 2021 ImmunoChip: European ancestry

Publications

Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes.
Robertson CC, Inshaw JRJ, et al.
Nat Genet. 2021 Jun 14. doi: 10.1038/s41588-021-00880-5.
PMID:34127860

Phenotypes

• Type 1 diabetes

Experiment summary

This dataset is the European-ancestry subset of T1DGC 2021 ImmunoChip: trans-ancestry, a meta-analysis of 16,159 unrelated T1D cases, 25,386 unrelated controls and 6,143 affected trios (where each trio includes an affected child and both of his/her parents). European-ancestry results are based on 13,458 unrelated cases and 20,143 controls.